Report cover image

Fresenius Kabi AG - Strategic SWOT Analysis Review

Publisher GlobalData
Published Jan 20, 2025
Length 41 Pages
SKU # GBDT19507542

Description

Fresenius Kabi AG - Strategic SWOT Analysis Review provides


- a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Fresenius Kabi AG (Fresenius Kabi), a subsidiary of Fresenius SE & Co KGaA is a healthcare company. It specializes in life-saving medicines and medical technologies, including intravenous (IV) drugs, medical nutrition, infusion technologies, cell therapies, blood collection, and biopharmaceuticals. Its product portfolio covers therapeutic areas such as oncology, anti-infectives, anesthesia, analgesia, and critical care. The company provides a wide range of injectable medications, pain management solutions, and critical care treatments. Fresenius Kabi also offers enteral and parenteral nutrition through its Fresubin range and advanced medical technologies like infusion pumps and apheresis devices. Its biopharmaceuticals focus on autoimmune diseases and oncology, supported by the KabiCare patient assistance program. Fresenius Kabi is headquartered in Bad Homburg, Germany.

Fresenius Kabi AG Key Recent Developments

Jan 16,2025: Fresenius Kabi Earns Top Employer Certification in 12 Countries
Oct 16,2024: Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Sep 26,2024: Advancing Medical Nutrition: Fresenius Kabi at ESPEN 2024
May 08,2024: Fresenius Raises Outlook for Fiscal 2024 Due to Excellent First Quarter

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

41 Pages
Section 1 - About the Company
Fresenius Kabi AG - Key Facts
Fresenius Kabi AG - Key Employees
Fresenius Kabi AG - Key Employee Biographies
Fresenius Kabi AG - Major Products and Services
Fresenius Kabi AG - History
Fresenius Kabi AG - Company Statement
Fresenius Kabi AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Fresenius Kabi AG - Business Description
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America/Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Kabi AG - Corporate Strategy
Fresenius Kabi AG - SWOT Analysis
SWOT Analysis - Overview
Fresenius Kabi AG - Strengths
Fresenius Kabi AG - Weaknesses
Fresenius Kabi AG - Opportunities
Fresenius Kabi AG - Threats
Fresenius Kabi AG - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2019 to YTD 2025
Fresenius Kabi AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 16, 2025: Fresenius Kabi Earns Top Employer Certification in 12 Countries
Oct 16, 2024: Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Sep 26, 2024: Advancing Medical Nutrition: Fresenius Kabi at ESPEN 2024
May 08, 2024: Fresenius Raises Outlook for Fiscal 2024 Due to Excellent First Quarter
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Fresenius Kabi AG, Key Facts
Fresenius Kabi AG, Key Employees
Fresenius Kabi AG, Key Employee Biographies
Fresenius Kabi AG, Major Products and Services
Fresenius Kabi AG, History
Fresenius Kabi AG, Other Locations
Fresenius Kabi AG, Subsidiaries
Fresenius Kabi AG, Joint Venture
Fresenius Kabi AG, Key Competitors
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2019 to YTD 2025
Fresenius Kabi AG, Recent Deals Summary
List of Figures
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
Fresenius Kabi AG, Medical Equipment, Deals by Type, 2019 to YTD 2025

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us